全球esketamine市場規模（按類型、應用、地區、範圍和預測）

esketamine市場規模與預測

2024 年esketamine市場規模價值為 15.4 億美元，預計 2032 年將達到 25 億美元，2026 年至 2032 年的複合年成長率為 6.23%。

市場的主要促進因素包括患者數量的增加、病情認知水平的提高、標準藥物治療缺乏效率和安全性以及限制因素、技術先進的醫療保健基礎設施的發展、與國際大學和知名供應商合作開展的有效esketamine的開發研究計劃。本研究報告對esketamine市場進行了全面的評估，包括關鍵細分市場、趨勢、市場促進因素、限制因素、競爭格局以及在市場中發揮重要作用的因素。

定義全球esketamine市場

esketamine，以 Ketanest 等品牌出售，是一種用於全身麻醉劑和抗治療性憂鬱症的藥物。esketamine可透過靜脈注射或滴鼻劑給藥。esketamine通常作為非競爭性 N-甲基-D-天冬胺酸受體拮抗劑發揮作用。

過去二十年，esketamine市場規模快速成長，同時，企業結構和員工行為模式也發生了變化，帶來了許多挑戰。全球esketamine市場正在經歷重大變革，製造商需要不斷創新才能維持其工作結構。

全球esketamine市場概覽

推動esketamine市場發展的因素包括：患者人數不斷增加、對疾病狀況的認知度不斷提高、標準藥物療法缺乏有效性和安全性、藥物動力學差異大、生物有效性低，以及易引起胃腸道反應和藥物交互作用 (DDI)。esketamine市場的機會在於其可靠的血腦屏障繞過方法、多種治療藥物的非侵入性給藥方式以及可觸發的製劑。

預計刺激全球esketamine市場的主要因素包括：增加對多種預防性esketamine研發計畫的投入，以及監管機構推出的物種健康相關指南。建造技術先進的醫療基礎設施，並與國際大學和知名供應商合作開展有效esketamine研發計劃，將為全球esketamine市場帶來豐厚的成長機會。然而，全球市場仍面臨挑戰，因為全球很大一部分人口（主要是新興經濟體）尚未有效利用esketamine。

然而，該行業設施營運和維護的高成本預計將阻礙因素市場成長。此外，合格專業人員的短缺也是市場成長的挑戰。非結構化資料過剩預計將減緩經濟成長。電子元件互連日益複雜、全球大宗商品價格下跌以及近期新冠疫情的爆發，為esketamine市場帶來了許多挑戰。然而，在預測期內，網路需求、智慧醫療基礎設施需求、醫療應用中的機器人技術以及基於感測器的設備的成長預計將為esketamine市場帶來重大機會。

目錄

第1章全球esketamine市場簡介

• 市場概覽
• 研究範圍
• 先決條件

第2章執行摘要

第3章：已驗證的市場研究調查方法

• 資料探勘
• 驗證
• 第一手資料
• 資料來源列表

第4章全球esketamine市場展望

• 概述
• 市場動態
  • 驅動程式
  • 限制因素
  • 機會
• 波特五力模型
• 價值鏈分析

第5章 全球esketamine市場（按類型）

• 概述
• 口服藥物
• 注射
• 滴鼻劑
• 其他

第6章 全球esketamine市場（依應用）

• 概述
• 全身麻醉劑
• 抗治療性憂鬱症

第7章全球esketamine市場（按地區）

• 概述
• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 德國
  • 英國
  • 法國
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 其他亞太地區
• 世界其他地區
  • 南美洲
  • 中東和非洲

第8章全球esketamine市場的競爭格局

• 概述
• 各公司市場排名
• 主要發展策略

第9章 公司簡介

• Merck
• Medkoo
• Endo International
• Janssen Pharmaceutica
• PFIZER.

第10章 附錄

• 相關調查

Esketamine Market Size And Forecast

Esketamine Market size was valued at USD 1.54 Billion in 2024 and is projected to reach USD 2.5 Billion by 2032, growing at a CAGR of 6.23% from 2026 to 2032.

Driving factors for the market are increased number of patients also Improved awareness level of disease state, lack of efficiency and safety of the standard pharmacological therapies and restraints, developing technologically advanced healthcare infrastructure, and ongoing research projects in association with international universities and prominent vendors for the development of effective esketamine. The Global Esketamine Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Esketamine Market Definition

Esketamine sold out under the brand name Ketanest among others, is a medication that is used as a general anesthetic and for treatment-resistant depression. Esketamine is used by putting injection into a vein or through a nasal spray. Esketamine acts generally as a non-competitive N-methyl-D-aspartate receptor antagonist.

Over the past two decades, the Esketamine Market has grown at an enormous scale, and over time it has brought many challenges with the change in the structure of the company and the way employees behave. The global Esketamine Market is undergoing significant changes, as the manufacturers need to evolve in an attempt to keep the structure of their work.

Global Esketamine Market Overview

Factors that drive Esketamine Market are the increased number of patients also Improved awareness level of disease state, lack of efficiency and safety of the standard pharmacological therapies and restraints for the following could be Pharmacokinetic variability, low bioavailability, and large propensity to cause gastrointestinal effects and DDI and the opportunities for Esketamine Market could be that it is a reliable method to bypass the BBB, non-invasive delivery of a wide range of therapeutic agents, Triggerable formulations.

Increasing investment in R&D programs for the development of several preventive Esketamine and guidelines provided by regulatory bodies associated with species health are the major factors expected to stimulate the global Esketamine Market. Developing technologically advanced healthcare infrastructure and ongoing research projects in association with international universities and prominent vendors for the development of effective Esketamine will provide lucrative growth opportunities to the global Esketamine Market. However, the global market faces challenges as a large percentage of the global population predominantly in developing economies is yet to efficiently utilize them.

However, the high costs associated with the operation and maintenance of facilities in the sector will be a hindrance to the growth of the market. In addition, the lack of qualified specialists will challenge the growth of the market. Excess of unstructured data is expected to slow economic growth. The increasing complexity of interconnecting electronic components, the drop in global commodity prices, and the recent outbreak of COVID-19 have brought up many challenges to Esketamine Market. Nevertheless, rising demand for networking, demand for smart healthcare infrastructure, robotics in healthcare applications, and sensor-based devices are expected to provide huge opportunities for the Esketamine Market for the forecasted period.

Global Esketamine Market Segmentation Analysis

The Global Esketamine Market is Segmented on the basis of Type, Application, And Geography.

Esketamine Market, By Type

• Oral Medications
• Injection
• Nasal Spray
• Others

Based on Type, the market is bifurcated into Oral Medications, Injection, Nasal Spray, and Others. Oral Medication dominated the global market in 2020 owing to its raw material abundance and is expected to continue the trend in the forecast period.

Esketamine Market, By Application

• General Anesthetic
• Treatment-resistant Depression

Based on Application, the market is bifurcated into General Anesthetic and Treatment-resistant Depression. General anesthesia is a condition of controlled unconsciousness. During general anesthesia, medications are used to send a patient to sleep, so patients do not know about the surgery and do not move or feel pain during the procedure.

Esketamine Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World

Based on Geography, the Global Esketamine Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. The North American region dominated the global market in 2020 owing to a large number of manufactures available in the region followed by Europe and is expected to continue the trend in the forecast period. The Asia Pacific region is expected to grow at a rapid pace in the forecast period owing to rapid urbanization and industrialization with an increased investment towards smart & efficient technology and increased per capita income.

Key Players

The "Global Esketamine Market" study report will provide a valuable insight with an emphasis on the global market including some of the major players such as Merck, Medkoo, Endo International, Janssen Pharmaceutica, and PFIZER.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL ESKETAMINE MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL ESKETAMINE MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL ESKETAMINE MARKET, BY TYPE

• 5.1 Overview
• 5.2 Oral Medications
• 5.3 Injection
• 5.4 Nasal Spray
• 5.5 Others

6 GLOBAL ESKETAMINE MARKET, BY APPLICATION

• 6.1 Overview
• 6.2 General Anesthetic
• 6.3 Treatment-resistant Depression

7 GLOBAL ESKETAMINE MARKET, BY GEOGRAPHY

• 7.1 Overview
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 U.K.
  • 7.3.3 France
  • 7.3.4 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Rest of Asia Pacific
• 7.5 Rest of the World
  • 7.5.1 South America
  • 7.5.2 Middle East and Africa

8 GLOBAL ESKETAMINE MARKET COMPETITIVE LANDSCAPE

• 8.1 Overview
• 8.2 Company Market Ranking
• 8.3 Key Development Strategies

9 COMPANY PROFILES

• 9.1 Merck
  • 9.1.1 Overview
  • 9.1.2 Financial Performance
  • 9.1.3 Product Outlook
  • 9.1.4 Key Developments
• 9.2 Medkoo
  • 9.2.1 Overview
  • 9.2.2 Financial Performance
  • 9.2.3 Product Outlook
  • 9.2.4 Key Developments
• 9.3 Endo International
  • 9.3.1 Overview
  • 9.3.2 Financial Performance
  • 9.3.3 Product Outlook
  • 9.3.4 Key Developments
• 9.4 Janssen Pharmaceutica
  • 9.4.1 Overview
  • 9.4.2 Financial Performance
  • 9.4.3 Product Outlook
  • 9.4.4 Key Developments
• 9.5 PFIZER.
  • 9.5.1 Overview
  • 9.5.2 Financial Performance
  • 9.5.3 Product Outlook
  • 9.5.4 Key Developments

10 Appendix

• 10.1 Related Research